U.S., European COVID-19 vaccine developers pledge to uphold testing rigour
FRANKFURT (Reuters) - Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the coronavirus pandemic.